Abstract: Poly cystic ovary syndrome [PCOS] represents the most common disorder in women during reproductive age. Because of the expensiveness and invasiveness of in vitro fertilization procedures [IVF], it has been tried to find a trustful, non invasive way for choosing embryos. Cell free DNA [cfDNA] extracted from follicular fluid can provide an indicator for embryo quality. Ovarian reserve has an important role in the occurrence of pregnancy in IVF programs, the aim of the study is measure the amount of cfDNA in the follicular fluid in females with PCOS undergoing intracytoplasmic sperm injection program and relating it to the ovarian reserve and embryo quality. This prospective study was accomplished in AL-Samaray Teaching Hospital in Baghdad from December 2017 to March 2017. Sixty females were involved in this study. Thirty one did not have PCOS [control] and 29 had PCOS. Blood samples........
Key words: AMH , cfDNA, embryo quality, ICSI, ovarian reserve , PCOS
[1]. Boivin J, Bunting L, Collins JA, et al, International estimates of infertility prevalence and treatment –seeking ;potential need and demand for infertility medical care, Hum Repord, 22, 2007, 1506-1612.
[2]. Mascarenhas MN, Flaxman SR, Boerma T, et al, National, Regional, and Global Trends in Infertility Prevalence Since 1990: A Systematic Analysis of 277 Health Surveys, PLoS Med j, 9[12], 2012, e1001356.
[3]. Gorry A, White DM, Franks S, Infertility in poly cystic ovary syndrome: focus on low dose gonadotropin treatment ,Endocrine, 30[1], 2006 ,27-33.
[4]. Cussons AJ, Watts GF, Burke V, et al. Cardiometabolic risk in polycystic ovary syndrome,A comparison of different approaches to defining the metabolic syndrome, Hum Reprod, 23, 2008, 2352–2358.
[5]. Czamanski-Cohen J, Sarid O, Cwikel J, et al, Increased plasma cell-free DNA is associated with low pregnancy rates among women undergoing IVF-embryo transfer, Reprod Biomed Online, 26, 2013, 36–41.